Clone 13-infected Aedes aegypti salivary components inhibit Rift Valley fever virus pathogenicity. - Archive ouverte HAL Access content directly
Journal Articles Microbes and Infection Year : 2014

Clone 13-infected Aedes aegypti salivary components inhibit Rift Valley fever virus pathogenicity.

(1) , (1) , (1) , (1, 2)
1
2

Abstract

Rift Valley fever virus (RVFV) continues to cause large outbreaks among humans and domestic animals in Africa. RVFV Clone 13, a naturally attenuated clone, is a promising vaccine which was used during the 2009-2010 outbreak in South Africa and played a key role in the control of the disease. In this work, we infected Aedes aegypti mosquitoes with RVFV Clone 13 and prepared salivary gland extracts (SGE). C57BL/6-NRJ male mice were infected with a mixture of SGE infected by Clone 13 and the ZH548 RVFV strain. With the injection of increasing doses of Clone 13-infected SGE, all mice were protected. Our results suggest Clone 13 infected SGE contain unique antiviral components able to counteract the replication of RVFV when injected into vertebrates.
Fichier principal
Vignette du fichier
Le_Coupanec_Clone_13.pdf (422.09 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Loading...

Dates and versions

pasteur-01054564 , version 1 (07-08-2014)

Licence

Copyright

Identifiers

Cite

Alain Le Coupanec, Divya Babin, Michèle Bouloy, Valérie Choumet. Clone 13-infected Aedes aegypti salivary components inhibit Rift Valley fever virus pathogenicity.. Microbes and Infection, 2014, pp.439-44. ⟨10.1016/j.micinf.2014.01.008⟩. ⟨pasteur-01054564⟩

Collections

PASTEUR
45 View
142 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More